Coriolis is a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs and vaccines.
As a family-owned and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our customers.
Founded in 2008, Coriolis is the expert in formulation development for liquid drugs, formulation and process development for freeze-dried products, well as analytical services including GMP (Good Manufacturing Practice) and legitimate release analysis.
We have supported the successful development of many drug products and formulations, and our scientists are eager to apply their experience on a large range of molecules (including proteins, peptides, monoclonal antibodies, RNA/DNA carrier systems, virus-like particles, viruses, bacteria and vaccines) to your project.
Our facts & figures
Foundation of Coriolis Pharma
Move to the IZB (Innovation and Start-Up Center for Biotechnology) in Martinsried
Biological Safety Level (BSL) 1 & 2 certification
Move to new facilities in Martinsried
10th anniversary of Coriolis Pharma